Skip to main content

GOLDMAN SACHS GROUP INC

Position in ORIC — Oric Pharmaceuticals, Inc.

CIK 886982 NEW YORK, NY

Position in ORIC

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$18,697,270
+$2,833,920 QoQ
Shares Held
1,475,712
-23.9% QoQ
Ownership
1.43%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 99.9908518735363.ToString("F0")% Shared 0.ToString("F0")% None 0.009148126463700236.ToString("F0")%

Common Shares in ORIC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,293,152,367 across 364 Biotechnology names. ORIC ranks #108 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ORIC

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $18,697,270 1,475,712
2025-12-31 $15,863,350 1,939,285
2025-09-30 $10,857,744 904,812
2025-06-30 $4,969,814 489,637
2025-03-31 $1,644,893 294,784
2024-12-31 $2,178,947 270,006
2024-09-30 $3,306,905 322,625
2024-06-30 $1,971,186 278,810
2024-03-31 $2,333,072 169,678
2023-12-31 $467,248 50,788
2023-09-30 $291,343 48,156
2023-06-30 $435,879 56,170
2023-03-31 $537,618 94,319
2022-09-30 $88,182 27,557
2022-06-30 $279,493 62,387
2022-03-31 $322,033 60,306
2021-12-31 $645,550 43,915
2021-09-30 $845,202 40,421
2021-06-30 $596,206 33,703
2021-03-31 $644,840 26,320
2020-12-31 $603,274 17,822
2020-09-30 $338,735 13,544
2020-06-30 $346,204 10,264